Stockreport

Promising Pediatric Data for Albireo’s A4250 to be Presented at The International Liver Congress™ 2017

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF Data supports advancement of A4250 into a planned Phase 3 trial in patients with progressive familial intrahepatic cholestasis Pruritus improvement and reduction in ser [Read more]